11.03
Schlusskurs vom Vortag:
$10.61
Offen:
$10.65
24-Stunden-Volumen:
203.67K
Relative Volume:
0.88
Marktkapitalisierung:
$122.64M
Einnahmen:
$346.10M
Nettoeinkommen (Verlust:
$-20.02M
KGV:
-6.0511
EPS:
-1.8228
Netto-Cashflow:
$-1.47M
1W Leistung:
+6.47%
1M Leistung:
-13.15%
6M Leistung:
+3.28%
1J Leistung:
-24.81%
Medifast Inc Stock (MED) Company Profile
Firmenname
Medifast Inc
Sektor
Branche
Telefon
(410) 581-8042
Adresse
1501 S. CLINTON STREET, BALTIMORE, MD
Compare MED vs ROL, SCI, FTDR, HRB, ANDG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MED
Medifast Inc
|
11.03 | 117.97M | 346.10M | -20.02M | -1.47M | -1.8228 |
|
ROL
Rollins Inc
|
42.14 | 20.10B | 3.84B | 529.30M | 621.14M | 1.0945 |
|
SCI
Service Corp International
|
76.75 | 10.48B | 4.33B | 535.79M | 486.05M | 3.79 |
|
FTDR
Frontdoor Inc
|
78.44 | 5.45B | 2.12B | 260.00M | 385.00M | 3.5067 |
|
HRB
H R Block Inc
|
39.34 | 4.83B | 3.91B | 736.10M | 760.88M | 5.6238 |
|
ANDG
Andersen Group Inc
|
36.88 | 4.24B | 871.37M | -163.01M | 0 | 1.0456 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Hochstufung | DA Davidson | Underperform → Neutral |
| 2024-06-05 | Herabstufung | DA Davidson | Neutral → Underperform |
| 2023-10-13 | Eingeleitet | Stephens | Equal-Weight |
| 2022-11-04 | Herabstufung | DA Davidson | Buy → Neutral |
| 2022-08-04 | Herabstufung | Jefferies | Buy → Hold |
| 2021-01-25 | Hochstufung | Jefferies | Hold → Buy |
| 2020-11-05 | Hochstufung | DA Davidson | Neutral → Buy |
| 2020-06-25 | Eingeleitet | B. Riley FBR | Buy |
| 2020-02-27 | Herabstufung | Jefferies | Buy → Hold |
| 2019-11-08 | Herabstufung | Dougherty & Company | Buy → Neutral |
| 2019-07-25 | Eingeleitet | Jefferies | Buy |
| 2018-11-08 | Hochstufung | Sidoti | Neutral → Buy |
| 2018-03-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2017-09-15 | Bestätigt | DA Davidson | Buy |
| 2016-08-04 | Bestätigt | Wunderlich | Hold |
| 2016-01-11 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-11-30 | Herabstufung | Sidoti | Buy → Neutral |
| 2015-10-05 | Hochstufung | Sidoti | Neutral → Buy |
| 2014-11-07 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2014-08-08 | Bestätigt | Imperial Capital | Outperform |
| 2014-04-23 | Bestätigt | Imperial Capital | Outperform |
| 2013-09-06 | Eingeleitet | Imperial Capital | Outperform |
| 2012-11-06 | Bestätigt | Northland Securities | Outperform |
| 2012-07-27 | Hochstufung | Northland Securities | Market Perform → Outperform |
| 2012-07-09 | Herabstufung | Standpoint Research | Buy → Hold |
| 2012-01-30 | Eingeleitet | Standpoint Research | Buy |
Alle ansehen
Medifast Inc Aktie (MED) Neueste Nachrichten
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Index - marketscreener.com
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Value-Defensive Index - marketscreener.com
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Value Benchmark - marketscreener.com
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Dynamic Index - marketscreener.com
Medifast, Inc.(NYSE: MED) dropped from Russell 3000E Index - marketscreener.com
Price to earnings forward of MEDIFAST INC – NYSE:MED - TradingView
Price to sales forward of MEDIFAST INC – NYSE:MED - TradingView
Price to earnings forward of Medifast, Inc. – BMV:MED - TradingView
OPTAVIA Essential 1 Bar from Medifast Inc.portion-controlled fuel for busy investors - AD HOC NEWS
Enterprise value to EBIT forward of Medifast, Inc. – BMV:MED - TradingView
Medifast, Inc. Actuals & Estimates (BMV:MED) - TradingView
Medifast, Inc. Actuals & Estimates (BOATS:MED) - TradingView
Enterprise value to EBITDA forward of MEDIFAST INC – NYSE:MED - TradingView
Enterprise value to revenue forward of MEDIFAST INC – NYSE:MED - TradingView
Enterprise value to revenue forward of Medifast, Inc. – BIVA:MED - TradingView
Medifast, Inc. Actuals & Estimates (LSE:0K05) - TradingView
Price to book forward of Medifast, Inc. – BIVA:MED - TradingView
Medifast, Inc. Actuals & Estimates (NYSE:MED) - TradingView
Price to sales forward of Medifast, Inc. – BIVA:MED - TradingView
Price to earnings forward of Medifast, Inc. – BIVA:MED - TradingView
Medifast Inc (MED) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MED Forecast — Price Target — Prediction for 2027 - TradingView
Medifast Inc (MED) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Medifast (MED) Loses 18.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Medifast Inc (MED) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Medifast refines its technical picture, shares trade in a narrow Nasdaq range - AD HOC NEWS
Why the Essential 1 Month Kit from Medifast quietly fits busy routines - AD HOC NEWS
MED News | MEDIFAST INC (NYSE:MED) - ChartMill
Medifast StockAnalyst expectations and business outlook - AD HOC NEWS
Medifast (MED) down 5.1% since last earnings report: Can it rebound? - MSN
Medifast Inc (MED) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Medifast Inc (MED) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Medifast Inc (MED) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Medifast Inc (MED) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Medifast Inc (MED) Valuation: PE, PB & Fair Value Analysis - TradingKey
Medifast Inc (MED) Institutional Confidence - TradingKey
New coaching twist, Medifast’s OPTAVIA app deepens its weight-loss ecosystem - AD HOC NEWS
Medifast Inc Stock (US58470S1024): valuation in focus after steep multi-year slide - AD HOC NEWS
What Science-Backed Subscription Health Programs Measure Differently - GlobeNewswire
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year? - Yahoo Finance
Medifast chief legal officer Jason Groves resigns; company begins search for successor - Investing.com UK
Medifast chief legal officer Jason Groves resigns; company begins search for successor By Investing.com - Investing.com South Africa
Medifast (MED) Files 8-K Announcing Executive Separation Agreement with Jason Groves - Minichart
Medifast's Jason L. Groves resigns as Chief Legal Officer & Corporate Secretary - TradingView
[8-K] MEDIFAST INC Reports Material Event - Stock Titan
MED News Today | Why did Medifast stock drop today? $MED - MarketBeat
Medifast (MED) director takes equity awards instead of cash for board service - Stock Titan
Medifast (NYSE: MED) director Kiai Parsa takes equity grants in lieu of cash fees - Stock Titan
Medifast (MED) director receives 11,680 RSUs as annual fee compensation - Stock Titan
Medifast (NYSE: MED) director receives 11,680 restricted stock units award - Stock Titan
Finanzdaten der Medifast Inc-Aktie (MED)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):